DarioHealth Corp. (DRIO) announced Wednesday morning that it has received the CE Mark for its Lightning-enabled version of the acclaimed Dario Blood Glucose Monitoring System. This will allow consumers to experience DarioHealth on the latest Apple devices.
Cree Inc. (CREE) reported first quarter EPS of $0.04 after the bell Tuesday, compared to $0.15 a year ago. The result was in line with analysts' expectations. The company expects to report second quarter EPS between a loss of $0.01 and a profit of $0.04. The consensus estimate is for EPS of $0.07.
Spectrum Pharmaceuticals Inc. (SPPI) announced Tuesday that the interim data from its Phase 2 clinical study of poziotinib in EGFR Exon 20 Mutant Non-Small-Cell Lung Cancer was presented in Yokohama, Japan.